238 related articles for article (PubMed ID: 188551)
21. Estrogen receptor binding to nuclei from normal and neoplastic rat mammary tissues in vitro.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1987 Jun; 47(11):2852-9. PubMed ID: 3105869
[TBL] [Abstract][Full Text] [Related]
22. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
23. Relationship between insulin and estrogen binding to growth response in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
Shafie SM; Hilf R
Cancer Res; 1978 Mar; 38(3):759-64. PubMed ID: 414834
[TBL] [Abstract][Full Text] [Related]
24. Direct inhibiting effects of [D-Trp6]gonadotropin-releasing hormone on the estrogen-sensitive progression of polyoma virus-induced mammary tumors in athymic mice.
Néri C; Blangy D; Schatz B; Drieu K; Berebbi M; Martin PM
Cancer Res; 1990 Sep; 50(18):5892-7. PubMed ID: 2168284
[TBL] [Abstract][Full Text] [Related]
25. Insulin binding and glucose transport in the R3230AC mammary adenocarcinoma.
Harmon JT; Hilf R
J Supramol Struct; 1976; 4(2):233-40. PubMed ID: 177815
[TBL] [Abstract][Full Text] [Related]
26. Effects of estradiol on insulin receptor distribution in primary cultures of R3230AC mammary adenocarcinoma of the rat.
Hilf R; Crofton DH
Endocrinology; 1985 Jan; 116(1):154-63. PubMed ID: 3880538
[TBL] [Abstract][Full Text] [Related]
27. Prolactin and estrogen binding in transplantable hormone-dependent and autonomous rat mammary carcinoma.
Costlow ME; Buschow RA; Richert NJ; McGuire WL
Cancer Res; 1975 Apr; 35(4):970-4. PubMed ID: 163700
[TBL] [Abstract][Full Text] [Related]
28. Effects of diabetes and insulin on phosphoinositide metabolism in R3230AC mammary tumors.
Narayanan U; Hilf R
Cancer Biochem Biophys; 1992 Nov; 13(2):93-101. PubMed ID: 1343852
[TBL] [Abstract][Full Text] [Related]
29. Effects of dietary lipids on lactogenic hormone receptor binding in rat mammary tumors.
Cave WT; Erickson-Lucas MJ
J Natl Cancer Inst; 1982 Feb; 68(2):319-24. PubMed ID: 6278191
[TBL] [Abstract][Full Text] [Related]
30. [Radioreceptor assay of prolactin].
Kato Y; Ohgo S; Imura H
Nihon Rinsho; 1976; 34(3):491-6. PubMed ID: 6810
[TBL] [Abstract][Full Text] [Related]
31. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
32. Effects of estradiol on the expression and production of IGFBP-2 by R3230AC mammary tumor cells.
Korc-Grodzicki B; Ren N; Hilf R
Oncol Res; 1996; 8(12):473-83. PubMed ID: 9160351
[TBL] [Abstract][Full Text] [Related]
33. Effects of streptozotocin-induced diabetes and insulin on phospholipid content of R3230AC mammary tumor cells.
Narayanan U; Ribes JA; Hilf R
Cancer Res; 1985 Oct; 45(10):4833-7. PubMed ID: 3896469
[TBL] [Abstract][Full Text] [Related]
34. Prolactin receptors and androgen-induced regression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma.
Costlow ME; Buschow RA; McGuire WL
Cancer Res; 1976 Sep; 36(9 pt.1):3324-9. PubMed ID: 184948
[TBL] [Abstract][Full Text] [Related]
35. Failure of indomethacin to inhibit growth of the R3230AC mammary tumor in rats.
Feldman JM; Hilf R
J Natl Cancer Inst; 1985 Oct; 75(4):751-6. PubMed ID: 3900514
[TBL] [Abstract][Full Text] [Related]
36. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
Soman V; Felig P
J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
[TBL] [Abstract][Full Text] [Related]
37. Prolactin regulation of cryptic prolactin receptors in cultured rat mammary tumor cells.
Costlow ME; Hample A
J Cell Physiol; 1984 Mar; 118(3):247-52. PubMed ID: 6321522
[TBL] [Abstract][Full Text] [Related]
38. Membrane-associated phosphatidylinositol kinase of R3230AC mammary tumors and normal mammary glands and effects of insulin on tumor enzyme activity.
Narayanan U; Keuker C; Hilf R
Cancer Res; 1988 Dec; 48(23):6727-32. PubMed ID: 2846158
[TBL] [Abstract][Full Text] [Related]
39. Comparison of the actions of the antiprogestin mifepristone (RU486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors.
Bakker GH; Setyono-Han B; Henkelman MS; de Jong FH; Lamberts SW; van der Schoot P; Klijn JG
Cancer Treat Rep; 1987 Nov; 71(11):1021-7. PubMed ID: 3119199
[TBL] [Abstract][Full Text] [Related]
40. Estradiol binding in ovariectomy-responsive and -nonresponsive rat mammary carcinoma.
Diamond EJ; Giladi M; Khan S; Hollander VP
Cancer Res; 1977 Jun; 37(6):1852-6. PubMed ID: 870188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
